December 3, 2021  -  InvestmentInvestment Round-upsNews

Femtech Investment Round-up (November 2021)

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is November 2021’s round-up.

Investments

Livongo founder Dr. Kimon Angelides’ FemTec Health comes out of stealth with $38M in funding, 3 acquisitions and a mission to transform women’s health.

Pregnancy nutrition startup Needed raises $5.8M to expand its offering and invest in clinical research.

The Lundquist Institute receives $3M from the NIH to expand its male contraception study.

UK-based healthtech company Forth raises £1.6M to invest in its female hormone mapping product.

Gynecological imaging startup Illumigyn raises $33M to invest in global expansion and research.

Maternal-fetal-health company Raydiant Oximetry raises $5M to support a clinical study at UTMB.

Antiva Biosciences raises a $31M Series D to take its HPV drug into clinical trials.

Mayo Clinic’s Marani Health raises $7.6M in seed funding for its digital platform for prenatal and postpartum care.

Techstars Grad SOS raises $3.4M to expand its “wellness-on-the-go” smart vending machine network to new locations.

Israeli femtech company MobileODT participates in India’s largest cervical cancer screening program.

Helaina raises a $20M Series A to scale production of its human breast milk proteins using precision fermentation.

Rosy closes a $2M seed round to invest in the development and growth of its platform for women’s sexual health.

Expecting raises a $1M seed round for its surrogate, egg donor and fertility clinic matching platform.

Schrödinger receives a $4.9M grant from the Gates Foundation to accelerate drug discovery in women’s health.

Acquisition

CooperCompanies announces plans to acquire reproductive health company Generate Life Sciences for $1.6B.

Other

Sofinnova Partners raises $548M to form Europe’s largest early-stage healthcare VC fund.